Research & Development



  衛青走了進來,順手將那道大紅文書撕碎,裝在袖子里,這才對一言不發的皇帝道︰“陛下,早做決斷啊。”   梁贊苦笑道︰“好在大師兄這幾年不再考教我們的武功了,也算是不幸中的大幸。”av   自己這幾天之所以跟長平爭鋒相對的目的,就是為了打擊長平,然後選擇衛青即將治病的前夕徹底干脆的質問長平一次。亚洲在线AV极品无码   藍田哼了一聲道︰“阿哲倒是會幫我,就是我父皇不同意,他明明沒有什麼可以教阿哲的,偏偏不放手,我就是想用阿哲,也得阿哲有時間啊。師傅,我知道咱們西北理工絕對不只有明面上的十幾個人,您把暗子給我幾個啊,等我掌控了長門宮,到時候拿長門宮當嫁妝,您看看,雲氏立刻就有了好大的一片基業啊。”   他一直認為這是智者才有的能力,他一眼看過去,驪山上除過長滿了樹木之外,沒什麼好看的。亚洲人妻av伦理   步行回行宮的劉徹走到宮門,見雲哲正在一絲不苟的寫字,他的眉頭就皺了起來。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo